NCS Multistage Holdings (NCSM) Research & Development (2024 - 2026)

NCS Multistage Holdings' Research & Development history runs 3 years deep, the most recent figure standing at $587000.0 for Q1 2026.

• On a quarterly basis, Research & Development rose 2.09% year-over-year to $587000.0 in Q1 2026; TTM through Mar 2026 was $2.4 million, a 13.01% increase from a year earlier, with the FY2025 full-year figure at $2.4 million, up 15.89% from the prior year.
• Research & Development declined to $587000.0 in Q1 2026 per NCSM's latest filing, from $612000.0 in the prior quarter.
• Across five years, Research & Development topped out at $656000.0 in Q3 2025 and bottomed at $501000.0 in Q2 2024.
• The 3-year median for Research & Development is $575000.0 (2025), against an average of $566333.3.
• Across the five-year window, Research & Development grew 20.15% in 2025 and grew 2.09% in 2026, its largest moves.
• Year by year, Research & Development stood at $531000.0 in 2024, then grew by 15.25% to $612000.0 in 2025, then slipped by 4.08% to $587000.0 in 2026.
• Per Business Quant, the three latest NCSM Research & Development figures stand at $587000.0 (Q1 2026), $612000.0 (Q4 2025), and $656000.0 (Q3 2025).